Generated by DeepSeek V3.2| John Skehel | |
|---|---|
| Name | John Skehel |
| Birth date | 6 March 1941 |
| Fields | Virology, Influenza, Molecular biology |
| Workplaces | National Institute for Medical Research, Francis Crick Institute |
| Alma mater | University of Birmingham, University of Wisconsin–Madison |
| Known for | Influenza virus structure and function, Hemagglutinin (influenza), Antiviral drug discovery |
| Awards | Fellow of the Royal Society, Knight Bachelor, Royal Medal |
John Skehel. Sir John James Skehel is a distinguished British virologist renowned for his pioneering research into the structure and function of the influenza virus. His seminal work, particularly on the viral hemagglutinin (influenza) protein, has fundamentally shaped the understanding of viral entry, antigenic drift, and the development of antiviral drugs and vaccine strategies. His long and influential career was primarily spent at the National Institute for Medical Research in Mill Hill, and he later became a key figure at the Francis Crick Institute.
John Skehel was born on 6 March 1941. He pursued his undergraduate studies in chemistry at the University of Birmingham, graduating with a Bachelor of Science degree. His interest in biological sciences then led him to undertake doctoral research in the United States at the University of Wisconsin–Madison. There, he earned his PhD for work on bacteriophage genetics, laying a foundational expertise in molecular biology under the guidance of prominent microbiologists. This formative period in Madison, Wisconsin provided critical training before he returned to the United Kingdom to embark on his career in virology.
Skehel joined the World Influenza Centre at the National Institute for Medical Research (NIMR) in 1966, beginning a decades-long association with the institute. His early research focused on the biology of influenza virus, and he rose to become Head of the Division of Virology. A landmark achievement was determining the three-dimensional structure of influenza hemagglutinin (influenza), a project conducted in collaboration with Don Wiley of Harvard University using X-ray crystallography. This work, published in the journal *Nature*, revealed the mechanism of viral entry into host cells and provided a structural basis for understanding antigenic variation. His laboratory also made significant contributions to characterizing neuraminidase, the other major influenza surface glycoprotein, and to studying cytotoxic T cell responses to infection. Following the closure of the NIMR, Skehel played a central role in the transition of research to the new Francis Crick Institute in London, where he served as Director from 2011 to 2015.
Skehel's contributions have been recognized by numerous prestigious awards and memberships. He was elected a Fellow of the Royal Society (FRS) in 1984. In 1996, he was appointed a Knight Bachelor for services to virology. He is a recipient of the Royal Medal from the Royal Society and the Marcel Benoist Prize. He has also received the Robert Koch Prize and the IUBMB Jubilee Medal. Skehel holds honorary doctorates from several universities, including the University of Bath and the University of Birmingham, and is an elected member of both the European Molecular Biology Organization and the Academy of Medical Sciences.
John Skehel is married to Dame Bridget Ogilvie, a noted parasitologist and former Director of the Wellcome Trust. The couple has been a prominent partnership in British biomedical science. Outside of his scientific work, Skehel has maintained a private life, with interests that include supporting the communication of science to the public. He has participated in various advisory roles for government and international bodies, including the World Health Organization, on matters concerning influenza pandemic preparedness and research policy.
Skehel's structural and functional studies of influenza virus proteins are considered classic works in virology, directly informing global efforts in influenza vaccine design and the development of drugs like zanamivir and oseltamivir. His leadership at the National Institute for Medical Research and the Francis Crick Institute helped shape the landscape of biomedical research in the UK. Through his mentorship of numerous scientists and his extensive publications in journals like *Nature* and *Science*, his legacy endures in the ongoing fight against influenza and other emerging viral threats. His work remains a cornerstone for understanding viral pathogenesis and immunity. Category:British virologists Category:Fellows of the Royal Society Category:Knights Bachelor Category:1941 births Category:Living people